25G and 22G Puncture Needles
Multicenter, Randomized, Self-matched Design, Positive Control, Non-inferiority Clinical Study of 25G and 22G Puncture Needles in Solid or Submucosal Pancreatic Masses
1 other identifier
observational
73
1 country
1
Brief Summary
The screened patients were randomly assigned 25G puncture needles and 22G puncture needles in a 1;1 ratio, based on the computer-generated random order, before receiving an ultrasound endoscope puncture. Each puncture needle puncture lesions 2 needles, the same type of puncture needle tissue samples taken in the same tissue pathology bottle, all tissues after the completion of the necessary cytological smears, are placed in the Formalin solution to send tissue pathology, pathologists do not know the order of distribution of 2 puncture needles to evaluate the tissue results, all pathology results are reported by the hospital pathology center, audit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2021
CompletedStudy Start
First participant enrolled
September 24, 2021
CompletedFirst Posted
Study publicly available on registry
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2022
CompletedNovember 8, 2021
September 1, 2021
7 months
September 18, 2021
November 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The acquisition rate of the core tissue sample
A core tissue sample is defined as a sample with an histological structure that is fully used for tissue evaluation of target lesions.
One week
Secondary Outcomes (3)
The length of the tissue strip
One week
the technical success rate 、the success rate of immunogrouping dyeing and the retention of the organizational structure
One week
the incidence of adverse events and the incidence of device defects
one week
Eligibility Criteria
The subjects were 18 years of age or older (inclusive) who were clinically diagnosed with solid pancreatic masses or submucosal masses and required endoscopic ultrasound-guided puncture examination. Seventy-three subjects are planned to be enrolled.
You may qualify if:
- Clinical diagnosis of real pancreatic swelling or submuscular swelling;
- Patients need to be guided by ultrasound endoscopy under the guidance of puncture to eliminate malignant lesions or clear lesions;
- Fully communicate before surgery, understand the risks and benefits of endoscopic operation, and sign an informed consent form.
You may not qualify if:
- There are endoscopic operation contraindications, including abnormal blood clotting, or long-term oral anticoagulant antiplatelet drugs, can not guarantee INR \< 1.5, or platelets less than 5 x 10 x 9 / L;
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
Biospecimen
Pancreatic or submucosal tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2021
First Posted
November 1, 2021
Study Start
September 24, 2021
Primary Completion
April 24, 2022
Study Completion
May 24, 2022
Last Updated
November 8, 2021
Record last verified: 2021-09